Biotech ., (2018f)
Vasan RS, Demissie S, Kimura M, Cupples LA, Rifai N, White C, Wang TJ, Gardner JP, Cao X, Benjamin EJ: Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the framingham heart study
Although 5% weight loss did not show a net benefit, Moll and colleagues noted that it could be net beneficial for some individuals, depending on their willingness to accept the harm outcomes. For example, one of the harm outcomes that highly influenced the unfavorable benefit-harm balance of tirzepatide was alopecia, they explained
This narrative approach allowed for comprehensive synthesis of current evidence while maintaining the flexibility to include diverse study designs and clinical perspectives relevant to understanding all aspects of DPN
Blood supply is absolutely critical during this phase
But here is where it gets complicated